1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Ankylosing Spondylitis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Disease-Modifying Anitrheumatic Drugs (DMARDs) 1.2.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) 1.2.4 Biologics 1.3 Market by Application 1.3.1 Global Ankylosing Spondylitis Treatment Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Juveniles 1.3.3 Adults 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Ankylosing Spondylitis Treatment Market Perspective (2016-2027) 2.2 Ankylosing Spondylitis Treatment Growth Trends by Regions 2.2.1 Ankylosing Spondylitis Treatment Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Ankylosing Spondylitis Treatment Historic Market Share by Regions (2016-2021) 2.2.3 Ankylosing Spondylitis Treatment Forecasted Market Size by Regions (2022-2027) 2.3 Ankylosing Spondylitis Treatment Industry Dynamic 2.3.1 Ankylosing Spondylitis Treatment Market Trends 2.3.2 Ankylosing Spondylitis Treatment Market Drivers 2.3.3 Ankylosing Spondylitis Treatment Market Challenges 2.3.4 Ankylosing Spondylitis Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Ankylosing Spondylitis Treatment Players by Revenue 3.1.1 Global Top Ankylosing Spondylitis Treatment Players by Revenue (2016-2021) 3.1.2 Global Ankylosing Spondylitis Treatment Revenue Market Share by Players (2016-2021) 3.2 Global Ankylosing Spondylitis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Ankylosing Spondylitis Treatment Revenue 3.4 Global Ankylosing Spondylitis Treatment Market Concentration Ratio 3.4.1 Global Ankylosing Spondylitis Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Ankylosing Spondylitis Treatment Revenue in 2020 3.5 Ankylosing Spondylitis Treatment Key Players Head office and Area Served 3.6 Key Players Ankylosing Spondylitis Treatment Product Solution and Service 3.7 Date of Enter into Ankylosing Spondylitis Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Ankylosing Spondylitis Treatment Breakdown Data by Type 4.1 Global Ankylosing Spondylitis Treatment Historic Market Size by Type (2016-2021) 4.2 Global Ankylosing Spondylitis Treatment Forecasted Market Size by Type (2022-2027) 5 Ankylosing Spondylitis Treatment Breakdown Data by Application 5.1 Global Ankylosing Spondylitis Treatment Historic Market Size by Application (2016-2021) 5.2 Global Ankylosing Spondylitis Treatment Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Ankylosing Spondylitis Treatment Market Size (2016-2027) 6.2 North America Ankylosing Spondylitis Treatment Market Size by Type 6.2.1 North America Ankylosing Spondylitis Treatment Market Size by Type (2016-2021) 6.2.2 North America Ankylosing Spondylitis Treatment Market Size by Type (2022-2027) 6.2.3 North America Ankylosing Spondylitis Treatment Market Size by Type (2016-2027) 6.3 North America Ankylosing Spondylitis Treatment Market Size by Application 6.3.1 North America Ankylosing Spondylitis Treatment Market Size by Application (2016-2021) 6.3.2 North America Ankylosing Spondylitis Treatment Market Size by Application (2022-2027) 6.3.3 North America Ankylosing Spondylitis Treatment Market Size by Application (2016-2027) 6.4 North America Ankylosing Spondylitis Treatment Market Size by Country 6.4.1 North America Ankylosing Spondylitis Treatment Market Size by Country (2016-2021) 6.4.2 North America Ankylosing Spondylitis Treatment Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Ankylosing Spondylitis Treatment Market Size (2016-2027) 7.2 Europe Ankylosing Spondylitis Treatment Market Size by Type 7.2.1 Europe Ankylosing Spondylitis Treatment Market Size by Type (2016-2021) 7.2.2 Europe Ankylosing Spondylitis Treatment Market Size by Type (2022-2027) 7.2.3 Europe Ankylosing Spondylitis Treatment Market Size by Type (2016-2027) 7.3 Europe Ankylosing Spondylitis Treatment Market Size by Application 7.3.1 Europe Ankylosing Spondylitis Treatment Market Size by Application (2016-2021) 7.3.2 Europe Ankylosing Spondylitis Treatment Market Size by Application (2022-2027) 7.3.3 Europe Ankylosing Spondylitis Treatment Market Size by Application (2016-2027) 7.4 Europe Ankylosing Spondylitis Treatment Market Size by Country 7.4.1 Europe Ankylosing Spondylitis Treatment Market Size by Country (2016-2021) 7.4.2 Europe Ankylosing Spondylitis Treatment Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Ankylosing Spondylitis Treatment Market Size (2016-2027) 8.2 Asia-Pacific Ankylosing Spondylitis Treatment Market Size by Type 8.2.1 Asia-Pacific Ankylosing Spondylitis Treatment Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Ankylosing Spondylitis Treatment Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Ankylosing Spondylitis Treatment Market Size by Type (2016-2027) 8.3 Asia-Pacific Ankylosing Spondylitis Treatment Market Size by Application 8.3.1 Asia-Pacific Ankylosing Spondylitis Treatment Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Ankylosing Spondylitis Treatment Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Ankylosing Spondylitis Treatment Market Size by Application (2016-2027) 8.4 Asia-Pacific Ankylosing Spondylitis Treatment Market Size by Region 8.4.1 Asia-Pacific Ankylosing Spondylitis Treatment Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Ankylosing Spondylitis Treatment Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Ankylosing Spondylitis Treatment Market Size (2016-2027) 9.2 Latin America Ankylosing Spondylitis Treatment Market Size by Type 9.2.1 Latin America Ankylosing Spondylitis Treatment Market Size by Type (2016-2021) 9.2.2 Latin America Ankylosing Spondylitis Treatment Market Size by Type (2022-2027) 9.2.3 Latin America Ankylosing Spondylitis Treatment Market Size by Type (2016-2027) 9.3 Latin America Ankylosing Spondylitis Treatment Market Size by Application 9.3.1 Latin America Ankylosing Spondylitis Treatment Market Size by Application (2016-2021) 9.3.2 Latin America Ankylosing Spondylitis Treatment Market Size by Application (2022-2027) 9.3.3 Latin America Ankylosing Spondylitis Treatment Market Size by Application (2016-2027) 9.4 Latin America Ankylosing Spondylitis Treatment Market Size by Country 9.4.1 Latin America Ankylosing Spondylitis Treatment Market Size by Country (2016-2021) 9.4.2 Latin America Ankylosing Spondylitis Treatment Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Ankylosing Spondylitis Treatment Market Size (2016-2027) 10.2 Middle East & Africa Ankylosing Spondylitis Treatment Market Size by Type 10.2.1 Middle East & Africa Ankylosing Spondylitis Treatment Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Ankylosing Spondylitis Treatment Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Ankylosing Spondylitis Treatment Market Size by Type (2016-2027) 10.3 Middle East & Africa Ankylosing Spondylitis Treatment Market Size by Application 10.3.1 Middle East & Africa Ankylosing Spondylitis Treatment Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Ankylosing Spondylitis Treatment Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Ankylosing Spondylitis Treatment Market Size by Application (2016-2027) 10.4 Middle East & Africa Ankylosing Spondylitis Treatment Market Size by Country 10.4.1 Middle East & Africa Ankylosing Spondylitis Treatment Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Ankylosing Spondylitis Treatment Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Abbvie 11.1.1 Abbvie Company Details 11.1.2 Abbvie Business Overview 11.1.3 Abbvie Ankylosing Spondylitis Treatment Introduction 11.1.4 Abbvie Revenue in Ankylosing Spondylitis Treatment Business (2016-2021) 11.1.5 Abbvie Recent Development 11.2 Amgen 11.2.1 Amgen Company Details 11.2.2 Amgen Business Overview 11.2.3 Amgen Ankylosing Spondylitis Treatment Introduction 11.2.4 Amgen Revenue in Ankylosing Spondylitis Treatment Business (2016-2021) 11.2.5 Amgen Recent Development 11.3 Janssen Biotech 11.3.1 Janssen Biotech Company Details 11.3.2 Janssen Biotech Business Overview 11.3.3 Janssen Biotech Ankylosing Spondylitis Treatment Introduction 11.3.4 Janssen Biotech Revenue in Ankylosing Spondylitis Treatment Business (2016-2021) 11.3.5 Janssen Biotech Recent Development 11.4 Merck 11.4.1 Merck Company Details 11.4.2 Merck Business Overview 11.4.3 Merck Ankylosing Spondylitis Treatment Introduction 11.4.4 Merck Revenue in Ankylosing Spondylitis Treatment Business (2016-2021) 11.4.5 Merck Recent Development 11.5 UCB 11.5.1 UCB Company Details 11.5.2 UCB Business Overview 11.5.3 UCB Ankylosing Spondylitis Treatment Introduction 11.5.4 UCB Revenue in Ankylosing Spondylitis Treatment Business (2016-2021) 11.5.5 UCB Recent Development 11.6 Boehringer Ingelheim 11.6.1 Boehringer Ingelheim Company Details 11.6.2 Boehringer Ingelheim Business Overview 11.6.3 Boehringer Ingelheim Ankylosing Spondylitis Treatment Introduction 11.6.4 Boehringer Ingelheim Revenue in Ankylosing Spondylitis Treatment Business (2016-2021) 11.6.5 Boehringer Ingelheim Recent Development 11.7 Johnson & Johnson 11.7.1 Johnson & Johnson Company Details 11.7.2 Johnson & Johnson Business Overview 11.7.3 Johnson & Johnson Ankylosing Spondylitis Treatment Introduction 11.7.4 Johnson & Johnson Revenue in Ankylosing Spondylitis Treatment Business (2016-2021) 11.7.5 Johnson & Johnson Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Ankylosing Spondylitis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Disease-Modifying Anitrheumatic Drugs (DMARDs) Table 3. Key Players of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Table 4. Key Players of Biologics Table 5. Global Ankylosing Spondylitis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Ankylosing Spondylitis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Ankylosing Spondylitis Treatment Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Ankylosing Spondylitis Treatment Market Share by Regions (2016-2021) Table 9. Global Ankylosing Spondylitis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Ankylosing Spondylitis Treatment Market Share by Regions (2022-2027) Table 11. Ankylosing Spondylitis Treatment Market Trends Table 12. Ankylosing Spondylitis Treatment Market Drivers Table 13. Ankylosing Spondylitis Treatment Market Challenges Table 14. Ankylosing Spondylitis Treatment Market Restraints Table 15. Global Ankylosing Spondylitis Treatment Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Ankylosing Spondylitis Treatment Market Share by Players (2016-2021) Table 17. Global Top Ankylosing Spondylitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ankylosing Spondylitis Treatment as of 2020) Table 18. Ranking of Global Top Ankylosing Spondylitis Treatment Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Ankylosing Spondylitis Treatment Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Ankylosing Spondylitis Treatment Product Solution and Service Table 22. Date of Enter into Ankylosing Spondylitis Treatment Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Ankylosing Spondylitis Treatment Market Size by Type (2016-2021) (US$ Million) Table 25. Global Ankylosing Spondylitis Treatment Revenue Market Share by Type (2016-2021) Table 26. Global Ankylosing Spondylitis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Ankylosing Spondylitis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Ankylosing Spondylitis Treatment Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Ankylosing Spondylitis Treatment Revenue Market Share by Application (2016-2021) Table 30. Global Ankylosing Spondylitis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Ankylosing Spondylitis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Ankylosing Spondylitis Treatment Market Size by Type (2016-2021) (US$ Million) Table 33. North America Ankylosing Spondylitis Treatment Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Ankylosing Spondylitis Treatment Market Size by Application (2016-2021) (US$ Million) Table 35. North America Ankylosing Spondylitis Treatment Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Ankylosing Spondylitis Treatment Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Ankylosing Spondylitis Treatment Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Ankylosing Spondylitis Treatment Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Ankylosing Spondylitis Treatment Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Ankylosing Spondylitis Treatment Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Ankylosing Spondylitis Treatment Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Ankylosing Spondylitis Treatment Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Ankylosing Spondylitis Treatment Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Ankylosing Spondylitis Treatment Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Ankylosing Spondylitis Treatment Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Ankylosing Spondylitis Treatment Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Ankylosing Spondylitis Treatment Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Ankylosing Spondylitis Treatment Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Ankylosing Spondylitis Treatment Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Ankylosing Spondylitis Treatment Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Ankylosing Spondylitis Treatment Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Ankylosing Spondylitis Treatment Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Ankylosing Spondylitis Treatment Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Ankylosing Spondylitis Treatment Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Ankylosing Spondylitis Treatment Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Ankylosing Spondylitis Treatment Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Ankylosing Spondylitis Treatment Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Ankylosing Spondylitis Treatment Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Ankylosing Spondylitis Treatment Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Ankylosing Spondylitis Treatment Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Ankylosing Spondylitis Treatment Market Size by Country (2022-2027) & (US$ Million) Table 62. Abbvie Company Details Table 63. Abbvie Business Overview Table 64. Abbvie Ankylosing Spondylitis Treatment Product Table 65. Abbvie Revenue in Ankylosing Spondylitis Treatment Business (2016-2021) & (US$ Million) Table 66. Abbvie Recent Development Table 67. Amgen Company Details Table 68. Amgen Business Overview Table 69. Amgen Ankylosing Spondylitis Treatment Product Table 70. Amgen Revenue in Ankylosing Spondylitis Treatment Business (2016-2021) & (US$ Million) Table 71. Amgen Recent Development Table 72. Janssen Biotech Company Details Table 73. Janssen Biotech Business Overview Table 74. Janssen Biotech Ankylosing Spondylitis Treatment Product Table 75. Janssen Biotech Revenue in Ankylosing Spondylitis Treatment Business (2016-2021) & (US$ Million) Table 76. Janssen Biotech Recent Development Table 77. Merck Company Details Table 78. Merck Business Overview Table 79. Merck Ankylosing Spondylitis Treatment Product Table 80. Merck Revenue in Ankylosing Spondylitis Treatment Business (2016-2021) & (US$ Million) Table 81. Merck Recent Development Table 82. UCB Company Details Table 83. UCB Business Overview Table 84. UCB Ankylosing Spondylitis Treatment Product Table 85. UCB Revenue in Ankylosing Spondylitis Treatment Business (2016-2021) & (US$ Million) Table 86. UCB Recent Development Table 87. Boehringer Ingelheim Company Details Table 88. Boehringer Ingelheim Business Overview Table 89. Boehringer Ingelheim Ankylosing Spondylitis Treatment Product Table 90. Boehringer Ingelheim Revenue in Ankylosing Spondylitis Treatment Business (2016-2021) & (US$ Million) Table 91. Boehringer Ingelheim Recent Development Table 92. Johnson & Johnson Company Details Table 93. Johnson & Johnson Business Overview Table 94. Johnson & Johnson Ankylosing Spondylitis Treatment Product Table 95. Johnson & Johnson Revenue in Ankylosing Spondylitis Treatment Business (2016-2021) & (US$ Million) Table 96. Johnson & Johnson Recent Development Table 97. Research Programs/Design for This Report Table 98. Key Data Information from Secondary Sources Table 99. Key Data Information from Primary Sources List of Figures Figure 1. Global Ankylosing Spondylitis Treatment Market Share by Type: 2020 VS 2027 Figure 2. Disease-Modifying Anitrheumatic Drugs (DMARDs) Features Figure 3. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Features Figure 4. Biologics Features Figure 5. Global Ankylosing Spondylitis Treatment Market Share by Application: 2020 VS 2027 Figure 6. Juveniles Case Studies Figure 7. Adults Case Studies Figure 8. Ankylosing Spondylitis Treatment Report Years Considered Figure 9. Global Ankylosing Spondylitis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Ankylosing Spondylitis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Ankylosing Spondylitis Treatment Market Share by Regions: 2020 VS 2027 Figure 12. Global Ankylosing Spondylitis Treatment Market Share by Regions (2022-2027) Figure 13. Global Ankylosing Spondylitis Treatment Market Share by Players in 2020 Figure 14. Global Top Ankylosing Spondylitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ankylosing Spondylitis Treatment as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Ankylosing Spondylitis Treatment Revenue in 2020 Figure 16. Global Ankylosing Spondylitis Treatment Revenue Market Share by Type (2016-2021) Figure 17. Global Ankylosing Spondylitis Treatment Revenue Market Share by Type (2022-2027) Figure 18. North America Ankylosing Spondylitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Ankylosing Spondylitis Treatment Market Share by Type (2016-2027) Figure 20. North America Ankylosing Spondylitis Treatment Market Share by Application (2016-2027) Figure 21. North America Ankylosing Spondylitis Treatment Market Share by Country (2016-2027) Figure 22. United States Ankylosing Spondylitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Ankylosing Spondylitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Ankylosing Spondylitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Ankylosing Spondylitis Treatment Market Share by Type (2016-2027) Figure 26. Europe Ankylosing Spondylitis Treatment Market Share by Application (2016-2027) Figure 27. Europe Ankylosing Spondylitis Treatment Market Share by Country (2016-2027) Figure 28. Germany Ankylosing Spondylitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Ankylosing Spondylitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Ankylosing Spondylitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Ankylosing Spondylitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Ankylosing Spondylitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Ankylosing Spondylitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Ankylosing Spondylitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Ankylosing Spondylitis Treatment Market Share by Type (2016-2027) Figure 36. Asia-Pacific Ankylosing Spondylitis Treatment Market Share by Application (2016-2027) Figure 37. Asia-Pacific Ankylosing Spondylitis Treatment Market Share by Region (2016-2027) Figure 38. China Ankylosing Spondylitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Ankylosing Spondylitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Ankylosing Spondylitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Ankylosing Spondylitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Ankylosing Spondylitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Ankylosing Spondylitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Ankylosing Spondylitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Ankylosing Spondylitis Treatment Market Share by Type (2016-2027) Figure 46. Latin America Ankylosing Spondylitis Treatment Market Share by Application (2016-2027) Figure 47. Latin America Ankylosing Spondylitis Treatment Market Share by Country (2016-2027) Figure 48. Mexico Ankylosing Spondylitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Ankylosing Spondylitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Ankylosing Spondylitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Ankylosing Spondylitis Treatment Market Share by Type (2016-2027) Figure 52. Middle East & Africa Ankylosing Spondylitis Treatment Market Share by Application (2016-2027) Figure 53. Middle East & Africa Ankylosing Spondylitis Treatment Market Share by Country (2016-2027) Figure 54. Turkey Ankylosing Spondylitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Ankylosing Spondylitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Ankylosing Spondylitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Abbvie Revenue Growth Rate in Ankylosing Spondylitis Treatment Business (2016-2021) Figure 58. Amgen Revenue Growth Rate in Ankylosing Spondylitis Treatment Business (2016-2021) Figure 59. Janssen Biotech Revenue Growth Rate in Ankylosing Spondylitis Treatment Business (2016-2021) Figure 60. Merck Revenue Growth Rate in Ankylosing Spondylitis Treatment Business (2016-2021) Figure 61. UCB Revenue Growth Rate in Ankylosing Spondylitis Treatment Business (2016-2021) Figure 62. Boehringer Ingelheim Revenue Growth Rate in Ankylosing Spondylitis Treatment Business (2016-2021) Figure 63. Johnson & Johnson Revenue Growth Rate in Ankylosing Spondylitis Treatment Business (2016-2021) Figure 64. Bottom-up and Top-down Approaches for This Report Figure 65. Data Triangulation Figure 66. Key Executives Interviewed

Abbvie Amgen Janssen Biotech Merck UCB Boehringer Ingelheim Johnson & Johnson